Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.

PubWeight™: 3.56‹?› | Rank: Top 1%

🔗 View Article (PMID 14769700)

Published in Circulation on February 09, 2004

Authors

Finlay A McAlister1, Justin Ezekowitz, Marcello Tonelli, Paul W Armstrong

Author Affiliations

1: Division of General Internal Medicine, University of Alberta, Edmonton, Canada. Finlay.McAlister@ualberta.ca

Articles citing this

(truncated to the top 100)

Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ (2006) 2.85

Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol (2006) 2.58

Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol (2013) 1.91

Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. J Card Fail (2008) 1.89

Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail (2009) 1.83

Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease. Circ Arrhythm Electrophysiol (2014) 1.66

Renal impairment predicts long-term mortality risk after acute myocardial infarction. J Am Soc Nephrol (2007) 1.57

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail (2011) 1.48

Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated? BMJ (2007) 1.34

Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the korean heart failure registry. Korean Circ J (2011) 1.34

Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol (2008) 1.21

Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines -- Heart Failure Program study. Am Heart J (2008) 1.12

Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study. Nephrol Dial Transplant (2008) 1.06

The natural history of preclinical diastolic dysfunction: a population-based study. Circ Heart Fail (2012) 1.02

The cardiorenal syndrome: a review. Int J Nephrol (2010) 1.00

Anemia and heart failure: a community study. Am J Med (2008) 1.00

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med (2015) 0.97

Prognostic importance of comorbidities in heart failure with preserved left ventricular ejection fraction. Heart Vessels (2010) 0.96

Epidemiology of chronic kidney disease in heart failure. Heart Fail Clin (2008) 0.95

Cardiorenal syndrome: a cardiologist's perspective of pathophysiology. Clin J Am Soc Nephrol (2013) 0.95

Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease. Atherosclerosis (2011) 0.94

Anticoagulation in heart failure: current status and future direction. Heart Fail Rev (2013) 0.93

Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging. BMC Cardiovasc Disord (2012) 0.90

A chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans. AIDS (2014) 0.89

The dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure. Heart Fail Rev (2012) 0.89

Predictors of re-hospitalization in patients with chronic heart failure. World J Cardiol (2012) 0.88

Cardiorenal syndrome: A literature review. Exp Clin Cardiol (2008) 0.88

Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes. Heart Fail Rev (2012) 0.88

Comparative effectiveness research in heart failure therapies: women, elderly patients, and patients with kidney disease. Heart Fail Clin (2012) 0.87

Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature. Heart Fail Rev (2013) 0.86

Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD. Kidney Int Suppl (2011) (2013) 0.86

Renal dysfunction is associated with shorter telomere length in heart failure. Clin Res Cardiol (2009) 0.85

Relationship between renal function and physical performance in elderly hospitalized patients. Rejuvenation Res (2012) 0.85

Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Perit Dial Int (2013) 0.84

The effects of comorbidity on the benefits and harms of treatment for chronic disease: a systematic review. PLoS One (2014) 0.84

Renal dysfunction in heart failure patients: what is the evidence? Heart Fail Rev (2007) 0.83

Prognostic Estimation of Advanced Heart Failure With Low Left Ventricular Ejection Fraction and Wide QRS Interval. Korean Circ J (2012) 0.83

Comorbid Heart Failure and Renal Impairment: Epidemiology and Management. Cardiorenal Med (2012) 0.83

Intrarenal Delivery of Mesenchymal Stem Cells and Endothelial Progenitor Cells Attenuates Hypertensive Cardiomyopathy in Experimental Renovascular Hypertension. Cell Transplant (2014) 0.83

Can we prevent or treat renal dysfunction in acute heart failure? Heart Fail Rev (2012) 0.83

The relevance of the primary prevention criteria for implantable cardioverter defibrillator implantation in korean symptomatic severe heart failure patients. Korean Circ J (2012) 0.82

Chapter 5: Referral to specialists and models of care. Kidney Int Suppl (2011) (2013) 0.82

Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure. Heart Vessels (2010) 0.82

Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels. Int J Chron Obstruct Pulmon Dis (2015) 0.81

Insulin resistance is an independent correlate of high serum levels of advanced glycation end products (AGEs) and low testosterone in non-diabetic men. Oxid Med Cell Longev (2016) 0.81

Cardiac Resynchronization Therapy in CKD Stage 4 Patients. Clin J Am Soc Nephrol (2015) 0.81

Low albumin levels and high impedance ratio as risk factors for worsening kidney function during hospitalization of decompensated heart failure patients. Exp Clin Cardiol (2013) 0.81

The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events. Heart Vessels (2008) 0.81

Identification and predicting short-term prognosis of early cardiorenal syndrome type 1: KDIGO is superior to RIFLE or AKIN. PLoS One (2014) 0.80

The cardiorenal syndrome: making the connection. Int J Nephrol (2010) 0.80

Cardiac resynchronization therapy: the issue of non-response. Heart Fail Rev (2012) 0.80

Managing anemia in patients with chronic heart failure: what do we know? Vasc Health Risk Manag (2010) 0.80

Use of a homecare electronic health record to find associations between patient characteristics and re-hospitalizations in patients with heart failure using telehealth. J Telemed Telecare (2013) 0.80

Worsening renal function in patients hospitalized with acute heart failure: risk factors and prognostic significances. Int J Nephrol (2010) 0.80

Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia. J Cardiovasc Pharmacol Ther (2016) 0.79

Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratification. PLoS One (2012) 0.79

The contribution of observational studies to the knowledge of drug effectiveness in heart failure. Br J Clin Pharmacol (2007) 0.79

Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia. J Saudi Heart Assoc (2012) 0.79

G Protein-Coupled Receptor-G-Protein βγ-Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure. J Am Soc Nephrol (2016) 0.78

Association of E/E' and NT-proBNP with renal function in patients with essential hypertension. PLoS One (2013) 0.78

Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int (2014) 0.78

M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics. J Am Heart Assoc (2014) 0.78

A retrospective characterization of worsening renal function in patients with acute decompensated heart failure receiving nesiritide. Pharm Pract (Granada) (2009) 0.78

Renal dysfunction in acute heart failure. Korean Circ J (2011) 0.78

Fractional excretion of sodium predicts worsening renal function in acute decompensated heart failure. Exp Clin Cardiol (2010) 0.78

Management of heart failure with preserved ejection fraction in a local public hospital in Hong Kong. BMC Cardiovasc Disord (2015) 0.78

The ability of NT-proBNP to detect chronic heart failure and predict all-cause mortality is higher in elderly Chinese coronary artery disease patients with chronic kidney disease. Clin Interv Aging (2013) 0.78

Heart failure, aging and beta-blockers: the need for more data on tolerability and efficacy. Clin Res Cardiol (2008) 0.78

The pathophysiology of the chronic cardiorenal syndrome: a magnetic resonance imaging study. Eur Radiol (2015) 0.78

Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction. Clin Kidney J (2012) 0.77

Diastolic heart failure: a confusing concept. Heart Fail Rev (2013) 0.77

Diminished renal function and the incidence of heart failure. Curr Cardiol Rev (2009) 0.77

Cardio-renal syndromes: from foggy bottoms to sunny hills. Heart Fail Rev (2011) 0.77

The Prognostic Importance of Changes in Renal Function during Treatment for Acute Heart Failure Depends on Admission Renal Function. PLoS One (2015) 0.77

Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol (2016) 0.77

The renal nerves in chronic heart failure: efferent and afferent mechanisms. Front Physiol (2015) 0.77

Therapies for acute heart failure in patients with reduced kidney function: a community-based perspective. Am J Kidney Dis (2008) 0.77

Prognostic significance of dilated inferior vena cava in advanced decompensated heart failure. Int J Cardiovasc Imaging (2014) 0.77

Can parathyroid hormone be used as a biomarker for heart failure? Heart Fail Rev (2013) 0.76

Obesity and chronic kidney disease in patients with chronic heart failure: an insight from the China Heart Survey. Clin Exp Nephrol (2011) 0.76

Management of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspective. J Diabetes Res (2014) 0.76

Can we prevent or treat renal dysfunction in chronic heart failure? Heart Fail Rev (2012) 0.75

Acidic urine is associated with poor prognosis in patients with chronic heart failure. Heart Vessels (2012) 0.75

Renal function, serum sodium level, and outcomes in hospitalized systolic heart failure patients: An analysis of the COAST study. Medicine (Baltimore) (2016) 0.75

Heart failure in subjects with chronic kidney disease: Best management practices. World J Cardiol (2010) 0.75

The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology. Biomark Insights (2007) 0.75

Renal dysfunction, restrictive left ventricular filling pattern and mortality risk in patients admitted with heart failure: a 7-year follow-up study. BMC Nephrol (2013) 0.75

Effect of renal function on prognosis in chronic heart failure. Am J Cardiol (2014) 0.75

Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies. Biochim Biophys Acta (2017) 0.75

The prognostic value of estimated glomerular filtration rate, amino-terminal portion of the pro-hormone B-type natriuretic peptide and parameters of cardiopulmonary exercise testing in patients with chronic heart failure. Heart Int (2012) 0.75

Cardiorenal Resynchronization Therapy: Strengthening the Heart and Kidneys. Clin J Am Soc Nephrol (2015) 0.75

Assessing Nephrological Competence among Geriatricians: A Proof of Concept Internet Survey. PLoS One (2015) 0.75

DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes. Cardiovasc Diabetol (2017) 0.75

Effectiveness of β-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease. J Card Fail (2013) 0.75

Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis (2014) 0.75

Antihypertensive treatment improves left ventricular diastolic function in patients with chronic kidney disease. Exp Ther Med (2015) 0.75

Explicit risk in acute coronary syndrome management. Can J Cardiol (2009) 0.75

Asthma in the elderly: a different disease? Breathe (Sheff) (2016) 0.75

Prevalence and prognostic impact of kidney disease on heart failure patients. Open Heart (2016) 0.75

Risk-adjustment models for heart failure patients' 30-day mortality and readmission rates: the incremental value of clinical data abstracted from medical charts beyond hospital discharge record. BMC Health Serv Res (2016) 0.75

Articles by these authors

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Universal definition of myocardial infarction. Circulation (2007) 11.69

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70

Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59

Third universal definition of myocardial infarction. Circulation (2012) 8.47

Relation between kidney function, proteinuria, and adverse outcomes. JAMA (2010) 8.26

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98

Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int (2011) 6.21

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet (2012) 5.65

Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol (2004) 5.61

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation (2007) 5.56

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31

The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension (2011) 5.14

Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA (2004) 5.11

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet (2002) 5.04

Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ (2011) 4.68

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49

Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation (2003) 4.43

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis (2010) 4.28

Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90

When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int (2009) 3.70

2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation (2007) 3.62

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62

Recommendations on screening for type 2 diabetes in adults. CMAJ (2012) 3.51

Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med (2003) 3.43

Recommendations on screening for cervical cancer. CMAJ (2013) 3.32

Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. Arch Intern Med (2012) 3.26

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med (2011) 3.20

Early recognition and prevention of chronic kidney disease. Lancet (2010) 3.19

Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation (2009) 3.18

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J (2006) 3.14

Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med (2011) 3.13

Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation (2005) 3.10

Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int (2013) 3.05

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int (2005) 3.03

Analysis and reporting of factorial trials: a systematic review. JAMA (2003) 3.02

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA (2007) 2.99

Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97

Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet (2010) 2.95

Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA (2007) 2.93

Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med (2014) 2.90

N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol (2013) 2.90

Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA (2004) 2.89

Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Kidney Int (2008) 2.88

Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol (2006) 2.84

Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol (2009) 2.82

International variation in and factors associated with hospital readmission after myocardial infarction. JAMA (2012) 2.75

Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA (2010) 2.61

Overview of the Alberta Kidney Disease Network. BMC Nephrol (2009) 2.58

Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int (2008) 2.56

Guidelines for the management of chronic kidney disease. CMAJ (2008) 2.54

Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA (2006) 2.53

Impact of specialist follow-up in outpatients with congestive heart failure. CMAJ (2005) 2.50

Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med (2009) 2.49

Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med (2011) 2.48

International differences in evolution of early discharge after acute myocardial infarction. Lancet (2004) 2.47

Rates of treated and untreated kidney failure in older vs younger adults. JAMA (2012) 2.43

Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation (2007) 2.42

Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA (2012) 2.38

Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis. Clin J Am Soc Nephrol (2007) 2.38

Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int (2004) 2.37

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32

Weekend hospital admission, acute kidney injury, and mortality. J Am Soc Nephrol (2010) 2.30

Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation (2007) 2.30

A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United States. Kidney Int (2004) 2.29

Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Eur Heart J (2013) 2.27

Aborted myocardial infarction: a new target for reperfusion therapy. Eur Heart J (2006) 2.26

Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet (2013) 2.22

Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy. JAMA (2012) 2.22

Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA (2008) 2.22

Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22

ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation (2008) 2.19

Population based screening for chronic kidney disease: cost effectiveness study. BMJ (2010) 2.19

Sex differences in mortality following acute coronary syndromes. JAMA (2009) 2.17

CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis (2009) 2.17

Proteinuria and life expectancy. Am J Kidney Dis (2012) 2.16

Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med (2003) 2.13

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation (2003) 2.09

The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events. Am J Med (2002) 2.09

Impact of anemia on hospitalization and mortality in older adults. Blood (2006) 2.07

Systematic review and meta-analysis: when one study is just not enough. Clin J Am Soc Nephrol (2008) 2.06

Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med (2008) 2.06

Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation (2006) 2.05

Short-term change in kidney function and risk of end-stage renal disease. Nephrol Dial Transplant (2012) 2.01

Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. Int J Cardiol (2013) 1.95

Access to health care among status Aboriginal people with chronic kidney disease. CMAJ (2008) 1.91

Chronic kidney disease and life expectancy. Nephrol Dial Transplant (2012) 1.90

Quality of care and mortality are worse in chronic kidney disease patients living in remote areas. Kidney Int (2010) 1.89

Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes. Clin J Am Soc Nephrol (2011) 1.89

Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation (2011) 1.85

Effects of fibrates in kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol (2012) 1.84